Core Outcome Measures in Effectiveness Trials

A core outcome set for clinical trails of Non-pharmacological Intervention for breast cancer related lymphedema (BCRL)

General Information

Lymphedema is one of the most important events after breast cancer surgery, not only can cause limitation of activity of shoulder , shape changing, but also have a negative impact on the patient's psychology and daily life and serious impact on the life quality of patients with breast cancer. Non-pharmacological therapy is becoming the first choice for the treatment of diseases recently. However, due to the inconsistent evaluation criteria of lymphedema, the remission rates of different therapies vary greatly, and the best treatment can not be chosen. Therefore, a series of accurate and effective assessment method(s) is needed, and it is necessary to establish a core outcome set(COS) for clinical trails of Non-pharmacological therapy for lymphedema after breast cancer surgery.

Organisation:Center for Clinical transformation and evaluation of acupuncture of Tianjin university of traditional Chinese medicine
Principal investigator: Li Hongyang

Further Study Information

Current Stage:
June 2017 - December 2017
Funding source(s):
No funding sources now,in the process of application

Health Area

Disease Category

Disease Name
Breast cancer

Target Population

Age Range
20 - 75


Nature / type of Intervention


Delphi process
Literature review
Systematic review

First,search all the datebases about Non-pharmacological Intervention for breast cancer related lymphedema and make a protocol and publish it,then take out all the outcomes,make a systematic review about them,then have meetings with clinical experts and patient representatives to set a core outcome set.

Stakeholders Involved

Clinical experts
Conference participants
Consumers (patients)
Patient/ support group representatives

Study Type

COS for clinical trials or clinical research

The site uses cookies, some may have been set already. Please refer to our privacy policy & cookie usage statement.
If you continue to use the site we'll assume you're happy to accept the cookies.